Show simple item record

dc.contributor.authorLarkin, Mary E.en_US
dc.contributor.authorBarnie, Annetteen_US
dc.contributor.authorBraffett, Barbara H.en_US
dc.contributor.authorCleary, Patricia A.en_US
dc.contributor.authorDiminick, Lisaen_US
dc.contributor.authorHarth, Judyen_US
dc.contributor.authorGatcomb, Patriciaen_US
dc.contributor.authorGolden, Ellenen_US
dc.contributor.authorLipps, Janieen_US
dc.contributor.authorLorenzi, Gayleen_US
dc.contributor.authorMahony, Carolen_US
dc.contributor.authorNathan, David M.en_US
dc.date.accessioned2015-08-03T14:02:22Z
dc.date.issued2014en_US
dc.identifier.citationLarkin, M. E., A. Barnie, B. H. Braffett, P. A. Cleary, L. Diminick, J. Harth, P. Gatcomb, et al. 2014. “Musculoskeletal Complications in Type 1 Diabetes.” Diabetes Care 37 (7): 1863-1869. doi:10.2337/dc13-2361. http://dx.doi.org/10.2337/dc13-2361.en
dc.identifier.issn0149-5992en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:17820878
dc.description.abstractOBJECTIVE The development of periarticular thickening of skin on the hands and limited joint mobility (cheiroarthropathy) is associated with diabetes and can lead to significant disability. The objective of this study was to describe the prevalence of cheiroarthropathy in the well-characterized Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort and examine associated risk factors, microvascular complications, and the effect of former DCCT therapy (intensive [INT] vs. conventional [CONV]) on its development. RESEARCH DESIGN AND METHODS This cross-sectional analysis was performed in 1,217 participants (95% of the active cohort) in EDIC years 18/19 after an average of 24 years of follow-up. Cheiroarthropathy—defined as the presence of any one of the following: adhesive capsulitis, carpal tunnel syndrome, flexor tenosynovitis, Dupuytren's contracture, or a positive prayer sign—was assessed using a targeted medical history and standardized physical examination. A self-administered questionnaire (Disabilities of the Arm, Shoulder and Hand [DASH]) assessed functional disability. RESULTS Cheiroarthropathy was present in 66% of subjects (64% of the INT group and 68% of the CONV group; P = 0.1640) and was associated with age, sex, diabetes duration, skin intrinsic fluorescence, HbA1c, neuropathy, and retinopathy (P < 0.005 for each). DASH functional disability scores were worse among subjects with cheiroarthropathy (P < 0.0001). CONCLUSIONS Cheiroarthropathy is common in people with type 1 diabetes of long duration (∼30 years) and is related to longer duration and higher levels of glycemia. Clinicians should include cheiroarthropathy in their routine history and physical examination of patients with type 1 diabetes because it causes clinically significant functional disability.en
dc.language.isoen_USen
dc.publisherAmerican Diabetes Associationen
dc.relation.isversionofdoi:10.2337/dc13-2361en
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067398/pdf/en
dash.licenseLAAen_US
dc.titleMusculoskeletal Complications in Type 1 Diabetesen
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden
dc.relation.journalDiabetes Careen
dash.depositing.authorLarkin, Mary E.en_US
dc.date.available2015-08-03T14:02:22Z
dc.identifier.doi10.2337/dc13-2361*
dash.authorsorderedfalse
dash.contributor.affiliatedLarkin, Mary
dash.contributor.affiliatedNathan, David


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record